Skip to content
The Great News – Lifestyle
Home
Sample Page
Author:
Cue Biopharma, Inc.
Cue Biopharma Announces $30 Million Private Placement
April 30, 2026
Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company
April 30, 2026
Cue Biopharma Announces 1-for-30 Reverse Stock Split
April 29, 2026
Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026
April 15, 2026
←
Previous Page
1
2